SHP-1: the next checkpoint target for cancer immunotherapy? (2016)

First Author: Watson HA
Attributed to:  Dissecting the impact of L-selectin on T lymphocyte dependent tumour immunity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1042/bst20150251

PubMed Identifier: 27068940

Publication URI: http://europepmc.org/abstract/MED/27068940

Type: Journal Article/Review

Volume: 44

Parent Publication: Biochemical Society transactions

Issue: 2

ISSN: 0300-5127